Cardiac Arrest News and Research

Latest Cardiac Arrest News and Research

Cameron Health completes enrollment in subcutaneous implantable defibrillator pivotal study

Cameron Health, Inc. announced today that it has completed enrollment in its pivotal FDA clinical study of the S-ICD System, the world's only completely subcutaneous implantable defibrillator.

5 May 2011

WAST NHS to equip its frontline ambulances with ZOLL E Series EMS monitor/defibrillator

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that the Welsh Ambulance Services NHS is equipping its frontline ambulances with the ZOLL E Series EMS monitor/defibrillator.

30 Apr 2011

Black cardiac arrest victims less apt to survive at hospitals: Study

Black cardiac arrest victims are more likely to die when they're treated in hospitals that care for a large black population than when they're brought to hospitals with a greater proportion of white patients, according to new research from the University of Pennsylvania School of Medicine.

30 Apr 2011

Cardiac Science receives European contract for automated external defibrillator

The wholly-owned subsidiary of Opto Circuits Ltd., Cardiac Science Corporation, a global leader in automated external defibrillator and diagnostic cardiac monitoring devices, has been awarded a contract to deploy 650 Powerheart AEDs in Girona, Spain, home to 700,000 Catalonians.

27 Apr 2011

Bioengineering students invent life-saving heart device

An invention by Rice University bioengineering students in collaboration with the Texas Heart Institute is geared toward giving immediate second chances to arrhythmia victims headed toward cardiac arrest.

27 Apr 2011

Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention program

The Government of Rwanda, together with QIAGEN N.V. and Merck, known as MSD outside the United States and Canada, today announced the launch, in Kigali, Rwanda, of a comprehensive national cervical cancer prevention program that includes vaccination with GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] for appropriate girls 12 to 15 years of age and modern molecular diagnostic screening for women between the ages of 35 and 45.

From QIAGEN Manchester Limited 25 Apr 2011

Cambridge Heart releases new MTWA software

Cambridge Heart, Inc., a developer of non-invasive diagnostic tests for cardiac disease, today announced the release of its redesigned Microvolt T-Wave Alternans software for its HearTwave II and CH2000 platforms.

25 Apr 2011

Canada Prime Minister announces $10 million fund for defibrillators and related training

Today Prime Minister Stephen Harper announced a $10 million plan to fund life-saving automated external defibrillators and related training in hockey arenas and community recreation centres across Canada.

22 Apr 2011

Stealth Peptides launches mitochondrion targeting compound Bendavia at Experimental Biology 2011

Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative mitochondrial therapies, introduced its lead clinical candidate, Bendavia™, a novel compound that targets the mitochondrion, during multiple scientific sessions of the Experimental Biology 2011 meeting.

20 Apr 2011

Baxter enters definitive agreement to acquire Prism

Baxter International Inc. announced today that it has entered into a definitive agreement to acquire privately-held Prism Pharmaceuticals, Inc., a specialty pharmaceutical company based in King of Prussia, PA. Prism Pharmaceuticals has developed and received U.S. Food and Drug Administration (FDA) approval for multiple presentations of NEXTERONE® (amiodarone HCl), an antiarrhythmic agent.

From Baxter International Inc. 18 Apr 2011

New publication on therapeutic hypothermia and temperature management

The successful use and evaluation of therapeutic hypothermia to improve survival and reduce the risk of neurological consequences following an out-of-hospital heart attack are explored in the premier issue of Therapeutic Hypothermia and Temperature Management, a new quarterly peer-reviewed journal published by Mary Ann Liebert, Inc.

8 Apr 2011

ZOLL begins shipments of new AED Plus version as per AHA, ERC Guidelines

ZOLL® Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that it has begun shipments of a new version of its AED Plus that is fully compliant with the new American Heart Association and European Resuscitation Council Guidelines issued in October of 2010.

8 Apr 2011

EKG test is a poor predictor of sudden death syndrome in young athletes

The sudden death of a young athlete always prompts full media attention, most recently spurring a call for preventative screening methods, including costly electrocardiogram tests for all school-age athletes.

6 Apr 2011

Stealth announces Bendavia Phase I clinical study results against ischemia reperfusion injury

Stealth Peptides Inc., a privately held biopharmaceutical company developing innovative therapies, announced today the results of a healthy volunteers Phase I clinical study of Bendavia™, a novel compound that targets the mitochondrion to treat ischemia reperfusion injury.

4 Apr 2011

Therapeutic hypothermia is an effective treatment for young adult patients with HCM

Young adult patients with genetic heart diseases, such as hypertrophic cardiomyopathy, substantially benefitted from therapeutic hypothermia, which could further extend the role for this treatment strategy in new patient populations, according to a scientific presentation at the American College of Cardiology Scientific Sessions in New Orleans, April 1-3.

4 Apr 2011

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

Merck, known as MSD outside of the United States and Canada, announced results from several new data analyses from the pivotal Phase III studies evaluating the addition of its investigational oral protease inhibitor VICTRELIS to peginterferon alfa-2b and ribavirin in adult patients with chronic hepatitis C virus genotype 1 infection.

1 Apr 2011

Doctors who use iResus application perform better simulated cardiac arrest emergency

Doctors who used a free iPhone application provided by the UK Resuscitation Council performed significantly better in a simulated medical emergency than those who did not, according to a study in the April issue of Anaesthesia.

29 Mar 2011

Pilot study shows feasibility of heart screening for risk of SCA in children

A pilot study in healthy children and adolescents shows that it is feasible to screen for undiagnosed heart conditions that increase the risk of sudden cardiac arrest.

18 Mar 2011

Sports medicine physician suggests cardiac screening for young athletes requires augmentation of existing diagnostics to achieve greater accuracy, become cost-effective

Sports medicine physician Steve Watts says cardiac screening for young athletes is useful in preventing sudden cardiac death and suggests new diagnostics have the potential to add value and change the debate about the viability of cardiac screening for young athletes in the United States.

17 Mar 2011

Wnt1 protein can improve function of endothelial progenitor cells

Circulating through the bloodstream of every human being is a rare and powerful type of cell, one that can actually create new blood vessels to bypass blockages that cause heart attacks and peripheral artery disease.

10 Mar 2011

Cardiac Arrest News and Research

Latest Cardiac Arrest News and Research

Cameron Health completes enrollment in subcutaneous implantable defibrillator pivotal study

WAST NHS to equip its frontline ambulances with ZOLL E Series EMS monitor/defibrillator

Black cardiac arrest victims less apt to survive at hospitals: Study

Cardiac Science receives European contract for automated external defibrillator

Bioengineering students invent life-saving heart device

Rwanda, QIAGEN and Merck launch comprehensive national cervical cancer prevention program

Cambridge Heart releases new MTWA software

Canada Prime Minister announces $10 million fund for defibrillators and related training

Stealth Peptides launches mitochondrion targeting compound Bendavia at Experimental Biology 2011

Baxter enters definitive agreement to acquire Prism

New publication on therapeutic hypothermia and temperature management

ZOLL begins shipments of new AED Plus version as per AHA, ERC Guidelines

EKG test is a poor predictor of sudden death syndrome in young athletes

Stealth announces Bendavia Phase I clinical study results against ischemia reperfusion injury

Therapeutic hypothermia is an effective treatment for young adult patients with HCM

Merck's VICTRELIS phase III study results against HCV presented at EASL annual meeting

Doctors who use iResus application perform better simulated cardiac arrest emergency

Pilot study shows feasibility of heart screening for risk of SCA in children

Sports medicine physician suggests cardiac screening for young athletes requires augmentation of existing diagnostics to achieve greater accuracy, become cost-effective

Wnt1 protein can improve function of endothelial progenitor cells

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Cardiac Arrest News and Research

Latest Cardiac Arrest News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in